Work

A Phase I/II Trial of the KSP Inhibitor ARRY-520 In Relapsed/Refractory Multiple Myeloma

Year: 2010

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v116.21.1959.1959

Authors: Jatin J Shah, Jeffrey A. Zonder, Adam Cohen, Donna Weber, Sheeba Thomas, Michael Wang, Jonathan L. Kaufman, Steven Michael Burt, Duncan Walker, Burgess Freeman, Selena Armistead Rush, Ann Ptaszynski, Robert Z. Orlowski, Sagar Lonial

Institutions: The University of Texas MD Anderson Cancer Center, Wayne State University, The Barbara Ann Karmanos Cancer Institute, Fox Chase Cancer Center, Emory University, Winship Cancer Institute, Array BioPharma (United States)

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2527913164

FWCI: 0.397

Cites:

Cited by: 6

Related to: 10